30. A 64-year-old man is brought to the emergency department with dizziness and
difficulty in breathing. He has a heart rate of 68 beats per minute and a blood
pressure of 76/40 mmHg. On auscultation he has generalised rhonchi and is
wheezy. There is no rash on examination. He states that he suffers from chronic
glaucoma and his ophthalmologist has recently changed his eye drops.
Which of the following eye drops is the most likely cause for this clinical picture?
A Phenylephrine
B Adrenaline
C Brimonidine
D Levobunolol
E Apraclonidine
30. D Levobunolol
Normal intraocular pressure (IOP) is 15-20 mmHg. Glaucoma is considered if the
IOP is greater than 20 mmHg. It contributes towards optic disc cupping and nerve
damage, which eventually leads to visual field defects and blindness if untreated.
Medical management includes topical eye drops. Circulatory absorption of drugs is
rapid through the nasolacrimal duct and the conjunctival capillaries.
Sympathomimetic agents such as 1% adrenaline, 0.1% dipivefrine (an adrenergic
prodrug), 0.2% brimonidine (α2-agonist) and 0.5% apraclonidine (α2-agonist) can be
used. They act by reducing rate of aqueous humor production and increased outflow
via the trabecular meshwork. Side effects include hypertension, arrhythmias and
myocardial ischaemia due to coronary vasospasm.
Adrenoceptor blocking agents including timolol, betaxolol and levobunolol act by
β-adrenoceptor blockage and reducing rate of aqueous humor production. Systemic
absorption of these can cause bradycardia, hypotension, bronchospasm and heart
failure.
This patient has presented with clinical features suggestive of bronchospasm
secondary to β-blocker, the most likely drug of which is levobunolol.